This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
In a volatile energy market, two durable picks stand out as no-brainer energy stocks right for many portfolios. Learn...
A renewed debate over using retirement savings to erase debt shines a light on tax rules, opportunity costs, and the ...
This summer, upgrade your investing skills with a practical summer reading list. Explore behavioral psychology, marke...
The SPDR S&P Metals & Mining ETF (XME) has surged toward a near-double over the past year, buoyed by gold and copper ...
A major fund boosted its Vicor stake, sending the stock higher as a 200% rally unfolds. This article unpacks the bet,...
Jim Cramer declares Broadcom undervalued after a solid earnings quarter with AI revenue accelerating; investors weigh...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
A cold email from a Dallas founder led Mark Cuban to back a nascent space company with $500,000. Today, Relativity Sp...
A leading LNG stock jumped 32% this stock year, investor took profits, and a massive exit followed. Here’s how to und...
SpaceX's IPO is on the horizon, but you can gain exposure today through a strategic backdoor. This article explains w...
Solana posted the largest ETF inflow in months on February 25, signaling renewed institutional interest. Yet on-chain...